ASP8302

· Astellas Pharma Europe B.V.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ASP8302, covering 2024-10-21 to 2024-11-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ASP8302 in Participants With Underactive Bladder [Phase 2]